Vaniqa Almirall, S.A. · Authorised · authorised 19 Mar 2001 · ATC D11AX
Therapeutic indication (EMA)
Treatment of facial hirsutism in women.
Active substance
Eflornithine
- US FDA 3
- EMA 2
- Health Canada 1
- NHS prices 1
- WHO EML 1
- Safety 1
US FDA United States — FDA approvals (Drugs@FDA)
EMA European Union — centrally authorised medicines
Ifinwil Norgine B.V. · Application withdrawn · ATC L01XX79
Therapeutic indication (EMA)
Treatment of high-risk neuroblastoma responsive to prior multiagent, multimodality therapy
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| VANIQA | 02243837 | 13.9 % / W/W | CREAM · TOPICAL | CIPHER PHARMACEUTICALS INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Eflornithine 11.5% cream | £56.87 | 60 gram | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 6.5.5.1.2. Medicines for the treatment of 2nd stage African trypanosomiasis · core
Gambiense trypanosomiasis
Parenteral > General injections > IV: 200 mg per mL in 50 mL bottle (hydrochloride)
Safety signals and safety-related labeling changes
- US FDA 26 Nov 2024 IWILFIN — safety-related labeling change
Labeling sections changed: Use in Specific Populations
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.